Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2001
10/09/2001US6300357 For therapy of mycotic disease of a human being and an animal
10/09/2001US6300347 For therapy of tumor necrosis factor and interleukin-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism, e.g. osteoporosis
10/09/2001US6300342 Antithrombotic phenylalkyl derivatives
10/09/2001US6300340 Useful for therapy of cancer and solid tumors
10/09/2001US6300338 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/09/2001US6300337 Acetamide derivative and use thereof
10/09/2001US6300333 Substituted piperidines, processes for their preparation and their use as pesticides and fungicides
10/09/2001US6300331 Naphthalimidobenzamide derivatives
10/09/2001US6300330 Blood coagulation factor x inhibitors as anticoagulants
10/09/2001US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents
10/09/2001US6300280 Compounds for herbicides and insecticides.
10/09/2001CA2177147C 2-oxoindoline derivative
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072740A1 Substituted 1-(4-aminophenyl) triazoles and their use as anti-inflammatory agents
10/04/2001WO2001072739A1 Method for preparing 3-(4-hydroxy-1h-indol-5-ylmethyl)-pyridinium compounds via enones
10/04/2001WO2001072738A1 Quinolonecarboxylic acid derivative
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072721A2 Synergistic methods and compositions for treating cancer
10/04/2001WO2001072718A1 Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072712A1 ISOQUINOLONE INHIBITORS OF FACTOR Xa
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072708A2 OXINDOLE INHIBITORS OF FACTOR Xa
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001029245A8 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS
10/04/2001WO2001019322A3 Use of csaids in rhinovirus infection
10/04/2001WO2000034255A9 Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin
10/04/2001WO2000033836A9 5-membered heterocycles for the treatment of human diseases involving modulators of selectins
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma
10/04/2001US20010027201 Non-systemic control of parasites
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027195 Indeno [1,2-c]pyrazol-4-ones and their uses
10/04/2001US20010027193 1-Diarylmethyl-4-alkyl or alkylsulfonylalkyl-azetidines; cannabinoid receptor antagonists; nervous system disorders (CNS); cardiovascular and glandular disorders; drug abuse; psychological disorders;
10/04/2001US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1138673A2 Novel carbamates and ureas as modifiers of multi-drug resistance
10/04/2001EP1137642A1 Bis-sulfonamides
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137639A1 Control of arthropods in animals
10/04/2001EP1137638A2 Isoquinoline derivatives
10/04/2001EP1137637A1 N-(2-phenyl-4-piperidinylbutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
10/04/2001EP1087962A4 Preparation of heteroaryl compounds
10/04/2001EP0973395A4 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/04/2001EP0925295B1 N-benzenesulphonyl-l-proline derivatives as b2 receptor antagonists of the bradykinin
10/04/2001EP0888304B1 Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same by 4-arylo-4-cyanoheptane dicarboxylic acid cyclisation, and use thereof for preparing 3-aryl-3-hydroxyalkylpiperidines
10/04/2001EP0874841B1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0841327B1 Triazole antifungal agent
10/04/2001EP0741712B1 Process for making hiv protease inhibitors
10/04/2001EP0698013B1 Fungicidal fused bicyclic pyrimidinones
10/04/2001EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
10/04/2001EP0631575B1 Substituted pyrimidines and their use as pesticides
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001EP0563384B1 Uracil derivative
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2408806A1 Quinolonecarboxylic acid derivative
10/04/2001CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2401242A1 Pharmaceutically active pyrrolidine derivatives
10/04/2001CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/03/2001CN1315951A FKBP inhibitors
10/03/2001CN1315943A Use of 5-amino-pyrazol-derivatives for combating micro-organisms
10/03/2001CN1315830A Treatment of anxiety disorders
10/03/2001CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates
10/03/2001CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists
10/03/2001CN1072219C Diazatropone, its production and use
10/03/2001CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/02/2001USH1996 Agriculture
10/02/2001US6297382 Compound and process for producing β-adrenergic receptor agonist
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297375 4-phenyl-pyridine derivatives
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
10/02/2001US6297299 Containing triazine groups
10/02/2001US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
10/02/2001US6297262 Use of 5-(2-ethyl-2h-tetrazol-5-yl)-1,2,3,6-tetrahydro-1-methylpyridi ne
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/02/2001US6297259 Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl) benzamides useful for the treatment of allergic diseases
10/02/2001US6297257 Benzazine derivatives phosphodiesterase 4 inhibitors
10/02/2001US6297256 Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
10/02/2001US6297252 Treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory.
10/02/2001US6297249 Integrin receptor antagonists
10/02/2001US6297247 Particularly stromelysin-1 and gelatinase a (72 kd gelatinase)
10/02/2001US6297239 Inhibitors of prenyl-protein transferase
10/02/2001US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases
10/02/2001US6297230 N-carbamoyl-substituted
10/02/2001US6297217 Boronic ester and acid compounds, synthesis and uses
10/02/2001US6296875 Method for producing a granule
10/02/2001CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
09/2001
09/27/2001WO2001070737A2 Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof
09/27/2001WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
09/27/2001WO2001070735A1 Heteroaromatic compounds having two-photon absorption activity
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
1 ... 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 ... 1080